Institute Of Chemical Biology

Research in the Weaver lab leads to discoveries that help secure partnership with Ancora Innovation LLC.  “Vanderbilt is at the forefront of genetic research. By understanding the genetic causes of disease opens exciting new opportunities to develop drugs to treat them more effectively,” said Matt Nelson, vice president, genetics and genomics, 3DC at Deerfield Management.  Read More

A bifunctional natural compound has been discovered with the potential to make antibiotic resistance to deadly infections less likely. Read More

A pair of Vanderbilt chemists have developed a faster, cheaper method for synthesizing ring molecules called cyclic depsipeptides found in antibiotics, anti-retrovirals and pesticides. Read More